Back to Directory

Barbara Eschenbach

Email

beschenbach@otsuka-europe.com

Phone

49 89 2060205-81

Institution

Otsuka Pharmaceutical Development & Commercialisation Europe GmbH

Address

Otsuka Pharmaceutical Development & Commercialisation Europe GmbH
Europa-Allee 52
Frankfurt am Main, 60327
Germany

Request an Update

Affiliated Studies

IMPAACT 2005: A Phase I/II Open-Label, Single-Arm Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Delamanid in Combination with Optimized Multidrug Background Regimen (OBR) in Children with MDR-TB with and without HIV

DAIDS Number

Research Area

Study Status